Staff Writer
The drug developer, backed by NEA, Jafco and others, raised $36 million in its IPO
Zosano, a drug developer backed by NEA, HBM Healthcare Investments and others, raised $49.5 million in its IPO
The med tech company, backed by Essex Woodlands, SV Life Sciences and others, held a $78.3 million IPO
The drug developer held a $86.4 million IPO
The company, backed by Scale, DFJ, USVP and others, held a $175 million IPO
The Copenhagen-based company went public on the Nasdaq in a $108 million offering
Founders Fund has made waves by becoming the first significant institutional firm to make a cannabis-focused investment. Will others make a similar leap?
Investors include Index Ventures, Tenaya Capital and Benchmark Capital
Investors include Bluestem Capital Partners.
Investors include RRE Ventures, Sapphire Ventures, First Round Capital, Institutional Venture Partners, Google Ventures, Tiger Global and others